Counterpoint: Limited life expectancy, basal cell carcinoma, health care today, and unintended consequences

Journal of the American Academy of Dermatology

Volumn 73, Issue 1, 2015, Pages 162-164

  Fosko, Scott W ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

access to care; basal cell carcinoma; delayed diagnoses; end of life care; limited life expectancy; narrow networks; skin cancer; unintended consequences

Indexed keywords

ADVANCED CANCER; ALGORITHM; ARTICLE; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER RISK; CANCER STAGING; COMORBIDITY; DELAYED DIAGNOSIS; DERMATOLOGIST; EARLY INTERVENTION; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; LIFE EXPECTANCY; PATIENT CARE; PRIORITY JOURNAL; CARCINOMA, BASAL CELL; CASE REPORT; MALE; PATIENT ABANDONMENT; RISK ASSESSMENT; SKIN NEOPLASMS; TERMINAL CARE; VERY ELDERLY;

AGED, 80 AND OVER; ALGORITHMS; CARCINOMA, BASAL CELL; HUMANS; LIFE EXPECTANCY; MALE; REFUSAL TO TREAT; RISK ASSESSMENT; SKIN NEOPLASMS; TERMINAL CARE;

EID: 84937899502     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2015.04.005     Document Type: Editorial

References (10)

1. E. Linos, T. Berger, and M.M. Chren Point: Care of potential low-risk basal cell carcinomas (BCCs) at the end of life. The key role of the dermatologist J Am Acad Dermatol 73 2015 158 161
2. E. Linos, R. Parvataneni, S.E. Stuart, W. Boscardin, C. Landefeld, and M. Chren Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer JAMA Intern Med 173 2013 1006 1012
3. J.S. Resneck Jr., A. Quiggle, M. Liu, and D.W. Brewster The accuracy of dermatology network physician directories posted by Medicare advantage health plans in an era of narrow networks JAMA Dermatol 150 2014 1290 1297
4. M. Beck Some cancer experts see "overdiagnosis," question emphasis on early detection Wall Street Journal September 14, 2014 Available from: URL: http://www.wsj.com/articles/some-cancer-experts-see-overdiagnosis-and-question-emphasis-on-early-detection-1410724838. Accessed January 29, 2015
5. L.J. Esserman, I.M. Thompson, B. Reid, and et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change Lancet Oncol 15 2014 e234 e242
6. B.M. Coldiron, R.J. Mellette Jr., G.J. Hruza, T.N. Helm, and C.A. Garcia Addressing overdiagnosis and overtreatment in cancer Lancet Oncol 15 2014 e307
7. E. Varga, I. Korom, Z. Raskó, and et al. Neglected basal cell carcinomas in the 21st century J Skin Cancer 2011 2011 392151
8. M.J. Eide, M.A. Weinstock, R.G. Dufresne, and et al. Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous cell carcinoma of the skin) J Invest Dermatol 124 2005 308 314
9. H1 Husein-Elahmed, M.T. Gutierrez-Salmeron, R. Naranjo-Sintes, and J. Aneiros-Cachaza Factors related to delay in the diagnosis of basal cell carcinoma J Cutan Med Surg 17 2013 27 32
10. K. Ball, L.A. Ross, D.W. Eby, L.J. Molnar, and T.M. Meuser Emerging issues in safe and sustainable mobility for older persons Accid Anal Prev 61 2013 138 140